Epirubitec 50mg Injection
By Epirubitec
Rx
1 Injection in a Vial

Composition
Epirubicin(50mg)

Manufacturer - United Biotech Pvt Ltd
FC/B-1 (Extn.), Mohan Co-operative Industrial Estate Mathura Road, New Delhi - 110 044

Expires on or after
April, 2026

liver
When using Epirubitec 50mg Injection, caution should be exercised in patients with liver disease. It may be necessary to adjust the dosage of the injection in such cases. It is important to consult your doctor before starting treatment with Epirubitec 50mg Injection if you have any liver issues. Patients with severe liver disease are advised not to use Epirubitec 50mg Injection. Consulting with your doctor is recommended to ensure the safe use of the medication in liver-related conditions.

kidney
Epirubitec 50mg Injection is likely safe for patients with kidney disease. Data suggests dose adjustment may not be necessary. Consult your doctor. Consider lower doses if serum creatinine is > 5 mg/dL.

alcohol
"Avoid consuming alcohol while using Epirubitec 50mg Injection due to safety concerns."

driving
Epirubitec 50mg Injection can cause side effects like nausea and vomiting, which may affect your ability to drive temporarily.

pregnancy
Epirubitec 50mg Injection is not safe to use during pregnancy. It poses a risk to the developing baby. Only in life-threatening situations, the doctor might prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Epirubitec 50mg Injection is considered unsafe for use while breastfeeding due to the potential risk of causing toxicity to the baby.
Habit Forming | No |
Chemical Class | Anthracycline Derivative |
Therapeutic Class | - |
Action Class | Alkaloids-cytotoxic agents |
₹2145
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025